Serum bile acids as a prognostic biomarker in biliary atresia following Kasai portoenterostomy.

"CONFLICT OF INTEREST Sanjiv Harpavat serves on a Data Safety Monitoring Board coordinated by Syneos Health. Kenneth D. R. Setchell consults for Travere Therapeutics and Mirum Pharmceuticals. He owns stock in Asklepion Pharmaceuticals and Aliveris SRL. Saul J. Karpen consults for Albireo, Intercept, and Mirum. Simon Horslen consults for Albireo. Kathleen M. Loomes consults for and received grants from Albireo and Mirum. She consults for Travere Therapeutics. Philip Rosenthal consults for and received grants from AbbVie, Arrowhead, and Dicerna. He consults for Albireo, Audentes, Encoded, and Gilead. He received grants from Ambys. Richard J. Thompson consults for and is on the speakers' bureau for Albireo and Mirum. He owns stock in and consults for Generation Bio and Rectify. Ronald J. Sokol advises Albireo and Mirum."

"FUNDING INFORMATION Supported by the National Institute of Diabetes, Digestive, and Kidney Diseases (U01 grants DK103149 to Baylor College of Medicine, DK062470 to Children's Healthcare of Atlanta, DK103135 to The Hospital for Sick Children, DK062436 to Ann & Robert H. Lurie Children's Hospital of Chicago, DK062497 to Cincinnati Children's Hospital Medical Center, DK103140 to University of Utah, DK084575 to Seattle Children's Hospital, DK062481 to the Children's Hospital of Philadelphia, DK062466 to Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center, DK062456 to University of Michigan, DK084536 to Riley Hospital for Children, DK062500 to University of California San Francisco Children's Hospital, DK084538 to Children's Hospital Los Angeles, DK062453 to Children's Hospital Colorado) and the National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Awards (UL1TR002378 to Children's Healthcare of Atlanta, UL1 TR000423 and UL1 RR025014 to Seattle Children's Hospital, UL1 TR001857 to Children's Hospital of Pittsburgh of UPMC, UL1 TR001878 and TR000003 to the Children's Hospital of Philadelphia, UL1 TR001872 to UCSF Children's Hospital, UL1TR00130 to Children's Hospital of Los Angeles, and UL1 TR002535 to University of Colorado). SH is also funded by NIH K23DK109207 and R03DK128535 as well as generous philanthropic support from Robert and Annie Graham. Funding information National Center for Advancing Translational Sciences, Grant/Award Number: UL1 RR025014, UL1 TR000003, UL1 TR000423, UL1 TR001857, UL1 TR001872, UL1 TR001878, UL1 TR002535, UL1TR00130 and UL1TR002378; National Institute of Diabetes and Digestive and Kidney Diseases, Grant/Award Number: DK062436, DK062453, DK062456, DK062466, DK062470, DK062481, DK062497, DK062500, DK084536, DK084538, DK084575, DK103135, DK103140 and DK103149; National Institutes of Health, Grant/Award Number: K23DK109207 and R03DK128535"